@ali_on_t's needle size claims for TRT, fact-checked

What did @ali_on_t actually say?

The creator showed two needles, an 18-gauge for drawing and a 25-gauge one-inch for injecting, and argued that many men avoid TRT because they assume large needles are required. Their core claim: most patients can do subcutaneous injections into belly fat rather than intramuscular injections, and this is "safer and much more convenient." That's a reasonable summary of where clinical practice has been drifting. The needle size comparison is accurate. An 18-gauge draw needle versus a 25-gauge injection needle is standard practice in many TRT protocols. The subcutaneous framing is where things get more interesting and deserve scrutiny.

Does the science back this up?

Mostly, yes, but with some important caveats. Subcutaneous testosterone injection is not some fringe approach. A study by Spratt et al. (2021, Journal of Clinical Endocrinology and Metabolism) found that subcutaneous testosterone cypionate produced stable serum testosterone levels comparable to intramuscular administration in hypogonadal men. Injection site reactions were manageable. Separately, research published by Goldberg et al. (2018, Sexual Medicine) compared subcutaneous and intramuscular routes and found subcutaneous dosing achieved adequate testosterone levels with smaller volumes and was preferred by patients for comfort. The "safer" claim is partially supported because subcutaneous injections avoid the nerve and vessel risks associated with deep intramuscular injections. However, "safer" is doing some heavy lifting here. The absolute risk of complications from intramuscular testosterone injections performed correctly is already low.

What did they get wrong (or right)?

They got the core mechanics right. A 25-gauge needle into subcutaneous abdominal tissue is genuinely less intimidating than a 23-gauge or larger needle going into the gluteus or thigh, and that patient psychology point is real. Needle anxiety is a documented barrier to self-injection adherence. Where the video falls short is precision. Saying subcutaneous injection is safer for "most patients" and "most doctors" recommend it overstates the consensus. Intramuscular injection remains the FDA-approved standard route for testosterone cypionate and enanthate. Subcutaneous use is off-label, which does not mean wrong, but the creator presented it as if it were the default without flagging that distinction. Some patients, particularly those with very low body fat, may not be ideal candidates for subcutaneous dosing. The video also does not address the pharmacokinetic differences: subcutaneous injections can produce slightly slower absorption and different peak-to-trough profiles, which matters for symptom management and lab interpretation.

What should you actually know?

If needle size is genuinely stopping you from exploring TRT, the creator's point is fair: small-gauge subcutaneous injections are a real, clinically used option. But the conversation should happen with a licensed prescribing clinician who reviews your labs, body composition, and injection technique. The route of administration affects how your testosterone levels behave between doses. Subcutaneous injections tend to produce lower peak testosterone concentrations and a flatter curve compared to intramuscular injections, which some patients prefer and others do not. A 2019 review by McBride et al. in Therapeutic Advances in Urology noted that subcutaneous administration is increasingly used in clinical practice but emphasized individualized dosing as essential. One more thing worth saying plainly: the needle you use does not change what testosterone does in your body. Route affects delivery kinetics, not the fundamental hormone. Do not let a video about needle size become the deciding factor in a treatment decision that warrants actual medical evaluation.